Skip to main content
SpringerLink
Log in

Mefloquine: MDR1 SNPs behind psychiatric disorders in women

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Aarnoudse ALHJ, Van Schaik RHN, Dieleman J, Molokhia M, van Riemsdijk MM, Ligthelm RJ, Overbosch D, van der Heiden IP, Stricker BHCh.MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine. Clinical Pharmacology and Therapeutics 80: 367-374, No. 4, Oct 2006

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mefloquine: MDR1 SNPs behind psychiatric disorders in women. React. Wkly. 1128, 1 (2006). https://doi.org/10.2165/00128415-200611280-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200611280-00001

Keywords

Search

Navigation